223 related articles for article (PubMed ID: 23856147)
1. [Progress of research on pressurized metered dose inhalers].
Zhou X
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147
[No Abstract] [Full Text] [Related]
2. HFA inhalers.
Koninck JC; Magro P; Khanjari F; Lemarié E; Diot P
Pediatr Pulmonol Suppl; 2004; 26():23-5. PubMed ID: 15029583
[No Abstract] [Full Text] [Related]
3. Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives.
Fabbri LM; Nicolini G; Olivieri D; Papi A
Expert Opin Pharmacother; 2008 Feb; 9(3):479-90. PubMed ID: 18220498
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
[TBL] [Abstract][Full Text] [Related]
5. CFC Phase-Out and the Chiesi Solution.
Huchon G; Fabbri LM
Respiration; 2005; 72 Suppl 1():1-2. PubMed ID: 15915005
[No Abstract] [Full Text] [Related]
6. Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.
Leach CL; Kuehl PJ; Chand R; McDonald JD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):127-33. PubMed ID: 26061801
[TBL] [Abstract][Full Text] [Related]
7. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
Braunstein G; Sharma R
Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
[No Abstract] [Full Text] [Related]
8. [Hydrofluoroalkane as a propellant for pressurized metered-dose inhalers: history, pulmonary deposition, pharmacokinetics, efficacy and safety].
Ibiapina CC; Cruz AA; Camargos PA
J Pediatr (Rio J); 2004; 80(6):441-6. PubMed ID: 15622419
[TBL] [Abstract][Full Text] [Related]
9. Extrafine aerosols and peripheral airway function in asthma.
Merkus PJ; Gappa M; Janssens H; Pijnenburg MW
Pediatr Pulmonol; 2012 Jun; 47(6):626; author reply 627. PubMed ID: 22081582
[No Abstract] [Full Text] [Related]
10. Comparative in vitro performance of three small-volume valved holding chambers with beclomethasone/formoterol pressurized metered dose inhaler.
Goncalves TM; Alhanout K; Nicolay A; Dubus JC; de Santana DP; Andrieu V
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):223-7. PubMed ID: 23094686
[TBL] [Abstract][Full Text] [Related]
11. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
Lipworth BJ; Jackson CM
Respir Med; 2000 Feb; 94(2):177; author reply 179-80. PubMed ID: 10714427
[No Abstract] [Full Text] [Related]
12. An anesthetic in use with bronchodilator inhaler: a fact less known.
Kummar P; Korula G; Ninan S; Karthikeyan C
Ann Card Anaesth; 2010; 13(1):77-8. PubMed ID: 20075547
[No Abstract] [Full Text] [Related]
13. Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers: potential advantages and disadvantages.
Tashkin DP
Chest; 1999 Feb; 115(2):316-8. PubMed ID: 10027423
[No Abstract] [Full Text] [Related]
14. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
[TBL] [Abstract][Full Text] [Related]
15. Qvar for Treatment of Chronic Asthma.
Jayanth A
Am Fam Physician; 2018 Apr; 97(8):538-539. PubMed ID: 29671500
[No Abstract] [Full Text] [Related]
16. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
Zhu B; Haghi M; Goud M; Young PM; Traini D
Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
[TBL] [Abstract][Full Text] [Related]
17. Aerosol therapy: assume nothing and require data.
Anderson PJ
Respir Care; 2003 Nov; 48(11):1016-8. PubMed ID: 14585111
[No Abstract] [Full Text] [Related]
18. [Efficacy and safety of a beta2-agonist-combination in patients with bronchial asthma--a clinical practice surveillance study].
Kanniess F
MMW Fortschr Med; 2010 Jan; 151 Suppl 4():188-92. PubMed ID: 21595147
[No Abstract] [Full Text] [Related]
19. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[TBL] [Abstract][Full Text] [Related]
20. On the superiority of BDP/FF HFA pMDI fixed combination over the free combination of BDP CFC pMDI and FF DPI.
García Arieta A
Respir Med; 2009 Dec; 103(12):1969-70; author reply 1971-2. PubMed ID: 19744845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
